20.9 million shares at US$17.25 per share
Gross proceeds approximately US$360.5 million
Toronto, January 21, 2009 - Kinross Gold
Corporation (TSX: K; NYSE: KGC) ("Kinross" or the "Company")
announced today that it has entered into an agreement with a
syndicate of underwriters led by UBS Securities Canada Inc. for a
bought deal public offering of 20.9 million common shares of
Kinross at a price of US$17.25 per common share. The Company has
also granted to the underwriters an over-allotment option,
exercisable for a period of 30 days from the date of closing of the
offering, to purchase up to an additional 3,135,000 common shares
at the offering price.
The gross proceeds of the offering will be approximately
US$360.5 million (US$414.6 million if the over-allotment option is
exercised in full). The Company intends to use the net proceeds of
the offering to enhance its capital position following the funding
of recent acquisitions and for general corporate purposes.
The common shares will be offered by way of a short form
prospectus in all of the provinces of Canada and will be registered
in the United States pursuant to a registration statement filed
under the multi-jurisdictional disclosure system, and may also be
offered on a private placement basis in certain jurisdictions
outside of Canada and the United States pursuant to applicable
prospectus exemptions. A registration statement relating to these
securities has been filed with the United States Securities and
Exchange Commission but has not yet become effective. The
securities may not be sold nor may offers to buy be accepted prior
to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale of
these common shares in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such
jurisdiction.
The offering is scheduled to close on or about February 5, 2009
and is subject to certain customary terms and conditions, including
normal regulatory approvals, including the approval of the Toronto
Stock Exchange. A copy of the prospectus relating to the securities
may be obtained in Canada from UBS Securities Canada Inc. at 161
Bay Street, Suite 4100, Toronto, Ontario M5J 2S1, or in the United
States from UBS Securities LLC at 299 Park Avenue, New York, NY
10171.
Cautionary Statement on Forward-Looking Information
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these common shares in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.